Results reveal an undiscovered role of SEMA3E in promoting pancreatic cancer pathogenesis, suggesting that SEMA3E as a suitable prognostic marker and therapeutic target for pancreatic cancer [26]. This evidence concerns the gene SEMA3E and pancreatic neoplasm.